Roche’s star MS medicine Ocrevus wins EU approval
ZURICH (Reuters) - The European Union approved Roche’s multiple sclerosis medicine Ocrevus, one the Swiss company’s key new drugs that likely neared $1 billion...
Developing Next Gen Multiple Sclerosis Therapies: Part 5
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies and drugs...
Multiple Sclerosis (MS) Symptoms: Torso Tightness (aka: “MS Hug”)
Overview:The “MS Hug” or “girdling” as it is often referred to is a feeling of tightness occurring in a person’s chest, waist and/or torso...
Intro to the MS Gym
If you have been cleared by your phycisian to start a fitness program and are new to the MS Gym, we recommend you download...
New Six-year Ocrevus (Ocrelizumab) Data Showed That Earlier Initiation and Continuation of Treatment Reduced...
Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in the risk of PPMS patients needing a wheelchair after...
Funding the Cure with Dr. Travis Stiles
I had the pleasure of interviewing Dr. Travis Stiles CEO of Novoron Bioscience, Inc. Novoron is a private biotech company developing novel therapeutic approaches in...
Novartis Announces FDA and EMA Filing Acceptance of Siponimod for Secondary Progressive Multiple Sclerosis...
Novartis announced this week that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's New Drug...
Health Canada approval last week of multiple sclerosis drug ‘absolutely a game-changer’
Global News - Joseph Petrilli said he cried for a long time when he heard that Health Canada approved a new drug that could...
Allcbdoilbenefits.com released the updated list of best pain relief oils for 2018
Blogger Aaron with allcbdoilbenefits.com compiled his annual list of the CBD oils that best help to control pain.What is CBD hemp oil and how...
USA Survey Shows Most Women Newly Diagnosed with MS Have Concerns They Aren’t Discussing...
FRAZER, Pa. and AVON, Colo.–(BUSINESS WIRE)–Approximately 400,000 people in the U.S. have Multiple sclerosis (MS), an unpredictable disease of the central nervous system that...
